Cargando…

SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors

Malignant rhabdoid tumor (MRT) is a highly malignant and often lethal childhood cancer. MRTs are genetically defined by bi-allelic inactivating mutations in SMARCB1, a member of the BRG1/BRM-associated factors (BAF) chromatin remodeling complex. Mutations in BAF complex members are common in human c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ning Qing, Paassen, Irene, Custers, Lars, Zeller, Peter, Teunissen, Hans, Ayyildiz, Dilara, He, Jiayou, Buhl, Juliane Laura, Hoving, Eelco Wieger, van Oudenaarden, Alexander, de Wit, Elzo, Drost, Jarno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692191/ https://www.ncbi.nlm.nih.gov/pubmed/38040699 http://dx.doi.org/10.1038/s41467-023-43498-3

Ejemplares similares

Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
por: Paassen, Irene, et al.
Publicado: (2023)

In vitro Modeling of Embryonal Tumors
por: Custers, Lars, et al.
Publicado: (2021)

The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid features
por: Wang, Yi-Wen, et al.
Publicado: (2021)

The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation
por: Han, Zhi-Yan, et al.
Publicado: (2016)

Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours
por: Custers, Lars, et al.
Publicado: (2021)

Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells
por: Darr, Jonatan, et al.
Publicado: (2015)

Targeting Polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor
por: Alimova, Irina, et al.
Publicado: (2017)

Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development
por: Vitte, Jeremie, et al.
Publicado: (2017)

ATRT-21. Contribution of germline mosaic alterations of SMARCB1 in rhabdoid tumor predisposition syndrome
por: Masliah-Planchon, Julien, et al.
Publicado: (2022)

SDPS-18 RHABDOID TUMOR PREDISPOSITION SYNDROME IN TWO INFANT SIBLINGS WITH ATYPICAL TERATOID RHABDOID TUMORS DUE TO A GERMLINE SMARCB1 MUTATION
por: Quintero, Ana, et al.
Publicado: (2023)

Erratum to: ‘Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells’
por: Darr, Jonatan, et al.
Publicado: (2016)

Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers
por: Richer, Wilfrid, et al.
Publicado: (2017)

Malignant rhabdoid tumor of the kidney in an adult with loss of INI1 expression and mutation in the SMARCB1 gene
por: Han, Eunkyung, et al.
Publicado: (2021)

Global Chromatin Changes Resulting from Single-Gene Inactivation—The Role of SMARCB1 in Malignant Rhabdoid Tumor
por: Kenny, Colin, et al.
Publicado: (2021)

ATRT-11. PREVALENCE OF GERMLINE VARIANTS IN SMARCB1 INCLUDING SOMATIC MOSAICISM IN AT/RT AND OTHER RHABDOID TUMORS
por: Shirai, Ryota, et al.
Publicado: (2020)

LIN28B is highly expressed in atypical teratoid/rhabdoid tumor (AT/RT) and suppressed through the restoration of SMARCB1
por: Choi, Seung Ah, et al.
Publicado: (2016)

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
por: Holdhof, Dörthe, et al.
Publicado: (2020)

SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression
por: Doucet-O’Hare, Tara T., et al.
Publicado: (2021)

Oncogenic roles of SMARCB1/INI1 and its deficient tumors
por: Kohashi, Kenichi, et al.
Publicado: (2017)

Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors
por: Algar, Elizabeth M., et al.
Publicado: (2009)

SMARCB1- and vimentin-positive esophageal carcinoma with undifferentiated components, rhabdoid features, and a good prognosis: a case report
por: Nagano, Hideki, et al.
Publicado: (2019)

Optical genome mapping identifies a germline retrotransposon insertion in SMARCB1 in two siblings with atypical teratoid rhabdoid tumors
por: Sabatella, Mariangela, et al.
Publicado: (2021)

Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor
por: Duan, Zejun, et al.
Publicado: (2022)

SMARCB1/INI1-Deficient Extrarenal Rhabdoid Tumor: A Case Report of a Rare and Aggressive Soft Tissue Sarcoma
por: Parker, Nathaniel A, et al.
Publicado: (2020)

SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature
por: Hua, Yinan, et al.
Publicado: (2020)

ATRT-06. SMARCB1 LOSS DRIVEN NON-CANONICAL PRC1 ACTIVITY REGULATES DIFFERENTIATION IN ATYPICAL TERATOID RHABDOID TUMORS (ATRT)
por: Alimova, Irina, et al.
Publicado: (2020)

Case report: administration of immune checkpoint inhibitor for SMARCB1 (INI1)-negative rhabdoid carcinoma with microsatellite instability (MSI)-high in the right colon
por: Kobayashi, Toshinori, et al.
Publicado: (2023)

Gene of the month: SMARCB1
por: Kalimuthu, Sangeetha N, et al.
Publicado: (2016)

SMARCB1 (INI1) retained but SMARCA4 (BRG1) negative atypical teratoid/rhabdoid tumor arising at the bilateral cerebellopontine angles: a case report
por: Mitsui, Nobuyuki, et al.
Publicado: (2021)

Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition
por: Simões, Maria Fernanda Evangelista, et al.
Publicado: (2022)

Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors
por: Pathak, Rajiv, et al.
Publicado: (2021)

Inhibition of MYC by the SMARCB1 tumor suppressor
por: Weissmiller, April M., et al.
Publicado: (2019)

SMARCB1(INI1)-deficient Sinonasal Basaloid Carcinoma: A Novel Member of the Expanding Family of SMARCB1-deficient Neoplasms
por: Agaimy, Abbas, et al.
Publicado: (2014)

SMARCB1/INI1-deficient tumors of adulthood
por: Parker, Nathaniel A., et al.
Publicado: (2020)

Microglia in pediatric brain tumors: The missing link to successful immunotherapy
por: du Chatinier, Aimée, et al.
Publicado: (2023)

WAPL maintains a cohesin loading cycle to preserve cell-type specific distal gene regulation
por: Liu, Ning Qing, et al.
Publicado: (2021)

peakC: a flexible, non-parametric peak calling package for 4C and Capture-C data
por: Geeven, Geert, et al.
Publicado: (2018)

Genotyping Cancer-Associated Genes in Chordoma Identifies Mutations in Oncogenes and Areas of Chromosomal Loss Involving CDKN2A, PTEN, and SMARCB1
por: Choy, Edwin, et al.
Publicado: (2014)

Human Pluripotent Stem Cell Fate Regulation by SMARCB1
por: Carmel-Gross, Ilana, et al.
Publicado: (2020)

Rhabdoid Carcinoma of the Rectum
por: Samalavicius, Narimantas Evaldas, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ddmphs52ila7r5uajv1l1omkbm